Intellia Therapeutics NTLA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 8.99 | 103.05 | -0.82 | -98,710 | -96 | |
| 2025Q3 | 17.27 | 110.02 | -0.92 | -111,477 | -101 | |
| 2025Q2 | 9.38 | 108.63 | -0.98 | -109,996 | -101 | |
| 2025Q1 | 7.11 | 105.67 | -1.10 | -120,807 | -114 | |
| 2024Q4 | 11.66 | 105.86 | -1.26 | -136,447 | -129 | |
| 2024Q3 | 20.55 | 106.67 | -1.35 | -144,770 | -136 | |
| 2024Q2 | 22.38 | 94.60 | -1.52 | -139,043 | -147 | |
| 2024Q1 | 27.51 | 106.11 | -1.12 | -114,003 | -107 | |
| 2023Q4 | 30.49 | -1.46 | -139,892 | -132 | ||
| 2023Q3 | 31.62 | 110.76 | -1.38 | -131,107 | -122 | |
| 2023Q2 | 40.78 | 110.57 | -1.41 | -132,334 | -124 | |
| 2023Q1 | 37.27 | 111.87 | -1.17 | -111,958 | -103 | |
| 2022Q4 | 34.89 | 99.93 | -1.38 | -110,087 | -113 | |
| 2022Q3 | 55.96 | 94.73 | -1.49 | -105,530 | -113 | |
| 2022Q2 | 51.76 | 100.90 | -1.33 | -98,301 | -101 | |
| 2022Q1 | 72.67 | 100.08 | -1.96 | -144,246 | -147 | |
| 2021Q4 | 118.24 | 100.63 | -1.10 | -80,415 | -81 | |
| 2021Q3 | 134.15 | 100.49 | -0.98 | -71,993 | -72 | |
| 2021Q2 | 161.91 | 100.31 | -1.01 | -69,017 | -69 | |
| 2021Q1 | 80.26 | 100.48 | -0.69 | -46,425 | -46 |